A Specific Mechanism for Late Loss of Cardiac Allograft: The Antibody Mediated Rejection (AMR) as a Major Factor of Cardiac Allograft Vasculopathy (CAV)

被引：0
|
作者：
Toquet, C. [1 ]
Loupy, A. [2 ]
Rouvier, P. [3 ]
Varnous, S. [3 ]
Cazes, A. [2 ]
Tible, M. [2 ]
Beuscart, T. [2 ]
Jouven, X. [2 ]
Bruneval, P. [2 ]
Van Huyen, J. -P. Duong [2 ]
机构：
[1] CHU Nantes, F-44035 Nantes 01, France
[2] Univ Paris 05, Paris, France
[3] Hop La Pitie Salpetriere, Paris, France
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2013年 / 32卷 / 04期
关键词：
D O I：
10.1016/j.healun.2013.01.626
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
669
引用
收藏
页码：S243 / S243
页数：1
相关论文
共 50 条
  • [1] Characterization of a specific mechanism for late loss of cardiac allograft: The antibody mediated rejection (AMR) as a major factor of cardiac allograft vasculopathy (CAV)
    Bruneval, P.
    Toquet, C.
    Loupy, A.
    Pouvier, P.
    Cazes, A.
    van Huyen, J. -P. Duong
    VIRCHOWS ARCHIV, 2012, 461 : S259 - S259
  • [2] Characterization of a specific mechanism for late loss of cardiac allograft: the antibody mediated rejection (AMR) as a major factor of cardiac allograft vasculopathy (CAV)
    Toquet, C.
    Loupy, A.
    Rouvier, P. H.
    Varnous, S.
    Cazes, A.
    Tible, M.
    Beuscart, T.
    Jouven, X.
    Bruneval, P.
    Van Huyen, J. P. Duong
    EUROPEAN HEART JOURNAL, 2012, 33 : 207 - 207
  • [3] Characterization of a Specific Mechanism for Late Loss of Cardiac Allograft: The Role of Antibody-Mediated Rejection
    Loupy, A.
    Toquet, C.
    Vernerey, D.
    Rouvier, P.
    Varnous, S.
    Tible, M.
    Beuscart, T.
    Lefaucheur, C.
    Bruneval, P.
    Duong, J.
    TRANSPLANTATION, 2014, 98 : 55 - 55
  • [4] Characterization of a Specific Mechanism for Late Loss of Cardiac Allograft: The Role of Antibody-Mediated Rejection
    Loupy, A.
    Toquet, C.
    Vernerey, D.
    Rouvier, P.
    Varnous, S.
    Tible, M.
    Beuscart, T.
    Lefaucheur, C.
    Bruneval, P.
    Duong, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 55 - 55
  • [5] Late Cardiac Allograft Failure, Cardiac Allograft Vasculopathy, and Antibody-Mediated Rejection: Untangling Some Knots?
    Burke, M. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (01) : 9 - 10
  • [6] The Impact of Late Antibody Mediated Rejection with Graft Dysfunction on Cardiac Allograft Vasculopathy and Survival
    Clerkin, K. J.
    Restaino, S. W.
    Marboe, C. C.
    Vasilescu, E. R.
    Zorn, E.
    Mancini, D. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S192 - S192
  • [7] Tocilizumab for Antibody-Mediated Rejection in the Setting of Cardiac Allograft Vasculopathy
    January, S.
    Pottebaum, A.
    Raymer, D.
    Lavine, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S38 - S39
  • [8] Late Failing Heart Allografts: Pathology of Cardiac Allograft Vasculopathy and Association With Antibody-Mediated Rejection
    Loupy, A.
    Toquet, C.
    Rouvier, P.
    Beuscart, T.
    Bories, M. C.
    Varnous, S.
    Guillemain, R.
    Pattier, S.
    Suberbielle, C.
    Leprince, P.
    Lefaucheur, C.
    Jouven, X.
    Bruneval, P.
    Huyen, J. P. Duong Van
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (01) : 111 - 120
  • [9] COMPARISON OF PURE ANTIBODY-MEDIATED REJECTION (AMR) WITH MIXED CELLULAR AND AMR IN REGARDS TO THE DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV) AND CARDIOVASCULAR MORTALITY (CVM) IN HEART TRANSPLANT PATIENTS
    Ozdemir, B. Handan
    Ayva, Sebnem
    Terzi, Aysen
    Sade, L. Elif
    Basturk, Bilkay
    Sezgin, Atilla
    TRANSPLANT INTERNATIONAL, 2019, 32 : 213 - 213
  • [10] Intracapillary Macrophages in Cardiac Allograft Biopsies for Diagnosis of Antibody-Mediated Rejection (AMR)
    Fedrigo, M.
    Feltrin, G.
    Benazzi, E.
    Poli, F.
    Frigo, A.
    Tona, F.
    Caforio, A.
    Castellani, C.
    Toscano, G.
    Gambino, A.
    Gerosa, G.
    Thiene, G.
    Angelini, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S42 - S42
12345